A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Colorectal Neoplasms
Prostate Neoplasm
Endometrial Neoplasms
Neoplasm Metastasis

Interventions

DRUG: LY4257496
DRUG: Standard of Care Anticancer Therapies
DIAGNOSTIC_TEST: LY4257529

Sponsor

Eli Lilly and Company